Yong-Moon Park
Concepts (321)
Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Diabetes Mellitus, Type 2 | 21 | 2025 | 486 | 5.120 |
Why?
| Obesity | 29 | 2023 | 1112 | 5.070 |
Why?
| Diet, Mediterranean | 8 | 2023 | 10 | 4.160 |
Why?
| Nutrition Surveys | 28 | 2023 | 103 | 3.940 |
Why?
| Republic of Korea | 42 | 2025 | 62 | 3.560 |
Why?
| Breast Neoplasms | 13 | 2025 | 1187 | 3.390 |
Why?
| Insulin Resistance | 13 | 2018 | 260 | 3.000 |
Why?
| Hypertension | 12 | 2025 | 541 | 2.750 |
Why?
| Cardiovascular Diseases | 14 | 2024 | 449 | 2.670 |
Why?
| Risk Factors | 54 | 2025 | 3644 | 2.600 |
Why?
| Blood Glucose | 15 | 2024 | 434 | 2.530 |
Why?
| Body Mass Index | 28 | 2022 | 658 | 2.320 |
Why?
| Middle Aged | 72 | 2025 | 12356 | 1.990 |
Why?
| Diet | 10 | 2023 | 554 | 1.900 |
Why?
| Female | 92 | 2025 | 26829 | 1.870 |
Why?
| Adult | 62 | 2025 | 13486 | 1.630 |
Why?
| Overweight | 6 | 2019 | 215 | 1.570 |
Why?
| Humans | 107 | 2025 | 50201 | 1.560 |
Why?
| Inflammation | 4 | 2022 | 608 | 1.560 |
Why?
| Proportional Hazards Models | 16 | 2025 | 408 | 1.470 |
Why?
| Diabetes Mellitus | 8 | 2024 | 281 | 1.450 |
Why?
| Health Surveys | 8 | 2020 | 235 | 1.440 |
Why?
| Aged | 49 | 2025 | 9505 | 1.430 |
Why?
| Triglycerides | 7 | 2020 | 153 | 1.420 |
Why?
| Siblings | 3 | 2021 | 33 | 1.410 |
Why?
| Prospective Studies | 21 | 2023 | 2396 | 1.400 |
Why?
| Metformin | 2 | 2021 | 63 | 1.380 |
Why?
| Blood Pressure | 13 | 2025 | 527 | 1.310 |
Why?
| Exercise | 7 | 2024 | 504 | 1.300 |
Why?
| Cross-Sectional Studies | 21 | 2023 | 1580 | 1.280 |
Why?
| Male | 67 | 2025 | 25572 | 1.260 |
Why?
| Postmenopause | 6 | 2022 | 76 | 1.240 |
Why?
| F2-Isoprostanes | 4 | 2023 | 8 | 1.210 |
Why?
| Income | 3 | 2024 | 101 | 1.110 |
Why?
| Feeding Behavior | 5 | 2022 | 177 | 1.070 |
Why?
| Aging | 5 | 2022 | 674 | 1.050 |
Why?
| Dementia | 2 | 2024 | 113 | 1.010 |
Why?
| Prevalence | 15 | 2023 | 960 | 1.000 |
Why?
| Waist Circumference | 11 | 2020 | 20 | 1.000 |
Why?
| Oxidative Stress | 5 | 2023 | 763 | 0.980 |
Why?
| Incidence | 16 | 2025 | 1000 | 0.970 |
Why?
| Circadian Rhythm | 1 | 2024 | 88 | 0.920 |
Why?
| Esophageal Neoplasms | 2 | 2022 | 104 | 0.910 |
Why?
| Cataract | 2 | 2015 | 43 | 0.890 |
Why?
| Attention Deficit Disorder with Hyperactivity | 2 | 2014 | 173 | 0.820 |
Why?
| Young Adult | 16 | 2024 | 4052 | 0.820 |
Why?
| Isoprostanes | 1 | 2022 | 2 | 0.800 |
Why?
| Cohort Studies | 22 | 2024 | 1414 | 0.780 |
Why?
| United States | 19 | 2023 | 4898 | 0.780 |
Why?
| Atrial Fibrillation | 1 | 2024 | 182 | 0.770 |
Why?
| Neoplasms | 4 | 2024 | 1233 | 0.760 |
Why?
| Periodontitis | 3 | 2019 | 10 | 0.760 |
Why?
| Hypoglycemia | 5 | 2022 | 52 | 0.750 |
Why?
| Cholesterol | 7 | 2021 | 148 | 0.750 |
Why?
| Diabetes, Gestational | 2 | 2022 | 52 | 0.720 |
Why?
| Body Weight | 5 | 2019 | 513 | 0.720 |
Why?
| Premenopause | 6 | 2018 | 24 | 0.720 |
Why?
| Cholesterol, HDL | 8 | 2021 | 35 | 0.710 |
Why?
| Age Factors | 6 | 2020 | 1096 | 0.690 |
Why?
| Aged, 80 and over | 11 | 2024 | 3158 | 0.690 |
Why?
| Follow-Up Studies | 14 | 2024 | 2188 | 0.670 |
Why?
| Risk Assessment | 4 | 2019 | 1255 | 0.660 |
Why?
| Acidosis | 1 | 2018 | 40 | 0.630 |
Why?
| Adenocarcinoma | 1 | 2022 | 402 | 0.620 |
Why?
| Coronary Artery Disease | 3 | 2025 | 273 | 0.620 |
Why?
| Stroke | 7 | 2024 | 479 | 0.610 |
Why?
| Intraocular Pressure | 2 | 2016 | 56 | 0.610 |
Why?
| Phenotype | 6 | 2023 | 732 | 0.600 |
Why?
| Physical Fitness | 2 | 2015 | 56 | 0.600 |
Why?
| Odds Ratio | 6 | 2018 | 548 | 0.600 |
Why?
| Plaque, Atherosclerotic | 1 | 2018 | 39 | 0.590 |
Why?
| Diabetic Angiopathies | 2 | 2018 | 17 | 0.570 |
Why?
| Hypertriglyceridemia | 2 | 2014 | 14 | 0.560 |
Why?
| Glaucoma, Open-Angle | 1 | 2016 | 22 | 0.550 |
Why?
| Alanine Transaminase | 2 | 2014 | 120 | 0.550 |
Why?
| Breast Feeding | 1 | 2018 | 189 | 0.540 |
Why?
| Insulin | 2 | 2018 | 460 | 0.530 |
Why?
| Myocardial Infarction | 5 | 2024 | 392 | 0.510 |
Why?
| Nutrition Assessment | 4 | 2021 | 64 | 0.500 |
Why?
| Lipids | 2 | 2015 | 147 | 0.500 |
Why?
| Ideal Body Weight | 1 | 2015 | 6 | 0.500 |
Why?
| Cause of Death | 4 | 2024 | 146 | 0.500 |
Why?
| Muscles | 1 | 2015 | 103 | 0.490 |
Why?
| Lipoproteins | 1 | 2015 | 39 | 0.490 |
Why?
| Zinc | 1 | 2015 | 53 | 0.480 |
Why?
| Energy Metabolism | 1 | 2017 | 284 | 0.480 |
Why?
| Metabolic Diseases | 1 | 2015 | 38 | 0.480 |
Why?
| Retrospective Studies | 15 | 2024 | 6190 | 0.470 |
Why?
| Colorectal Neoplasms | 3 | 2024 | 255 | 0.450 |
Why?
| Antihypertensive Agents | 2 | 2012 | 126 | 0.450 |
Why?
| Diabetic Retinopathy | 1 | 2014 | 39 | 0.440 |
Why?
| Sex Factors | 6 | 2017 | 700 | 0.430 |
Why?
| Body Composition | 1 | 2015 | 326 | 0.430 |
Why?
| Intellectual Disability | 2 | 2024 | 128 | 0.430 |
Why?
| Sarcopenia | 1 | 2014 | 94 | 0.420 |
Why?
| Bipolar Disorder | 1 | 2014 | 193 | 0.420 |
Why?
| Menopause | 1 | 2013 | 40 | 0.410 |
Why?
| Depressive Disorder, Major | 1 | 2014 | 150 | 0.410 |
Why?
| Ferritins | 1 | 2012 | 30 | 0.410 |
Why?
| Sleep | 3 | 2024 | 179 | 0.390 |
Why?
| Dinoprost | 3 | 2022 | 8 | 0.390 |
Why?
| Prognosis | 8 | 2021 | 1963 | 0.380 |
Why?
| Socioeconomic Factors | 4 | 2018 | 584 | 0.380 |
Why?
| Fasting | 3 | 2018 | 72 | 0.380 |
Why?
| Adipose Tissue | 1 | 2013 | 191 | 0.380 |
Why?
| Diabetes Complications | 1 | 2012 | 118 | 0.380 |
Why?
| Health Status | 3 | 2015 | 299 | 0.380 |
Why?
| Health Knowledge, Attitudes, Practice | 2 | 2012 | 489 | 0.370 |
Why?
| Percutaneous Coronary Intervention | 2 | 2025 | 299 | 0.360 |
Why?
| Databases, Factual | 5 | 2024 | 660 | 0.350 |
Why?
| Kidney Failure, Chronic | 2 | 2025 | 199 | 0.340 |
Why?
| Comorbidity | 3 | 2018 | 612 | 0.330 |
Why?
| Rural Population | 4 | 2025 | 551 | 0.330 |
Why?
| Meat | 2 | 2019 | 61 | 0.320 |
Why?
| Hypoglycemic Agents | 2 | 2021 | 169 | 0.310 |
Why?
| National Health Programs | 2 | 2024 | 18 | 0.290 |
Why?
| Glucose Intolerance | 2 | 2019 | 27 | 0.290 |
Why?
| Sex Distribution | 4 | 2015 | 135 | 0.280 |
Why?
| Medicaid | 3 | 2014 | 256 | 0.280 |
Why?
| Obesity, Abdominal | 3 | 2022 | 14 | 0.270 |
Why?
| Cardiovascular System | 2 | 2018 | 50 | 0.260 |
Why?
| Case-Control Studies | 4 | 2025 | 1145 | 0.260 |
Why?
| Autonomic Nervous System | 2 | 2018 | 57 | 0.250 |
Why?
| Lighting | 1 | 2024 | 5 | 0.240 |
Why?
| Light | 1 | 2024 | 70 | 0.230 |
Why?
| Air Pollutants | 1 | 2025 | 65 | 0.230 |
Why?
| Logistic Models | 3 | 2018 | 901 | 0.230 |
Why?
| Anthracyclines | 1 | 2024 | 29 | 0.230 |
Why?
| Adolescent | 7 | 2023 | 6459 | 0.220 |
Why?
| Energy Intake | 2 | 2022 | 170 | 0.220 |
Why?
| Receptors, Estrogen | 2 | 2021 | 130 | 0.220 |
Why?
| Educational Status | 2 | 2015 | 225 | 0.210 |
Why?
| Environmental Exposure | 1 | 2025 | 200 | 0.210 |
Why?
| Survivors | 1 | 2024 | 120 | 0.210 |
Why?
| Cooking | 2 | 2019 | 18 | 0.210 |
Why?
| Antibodies, Bacterial | 2 | 2019 | 27 | 0.210 |
Why?
| Lutein | 1 | 2022 | 4 | 0.200 |
Why?
| beta Carotene | 1 | 2022 | 9 | 0.200 |
Why?
| Carotenoids | 1 | 2022 | 25 | 0.200 |
Why?
| Time Factors | 5 | 2020 | 2909 | 0.200 |
Why?
| Nutritional Physiological Phenomena | 1 | 2022 | 21 | 0.200 |
Why?
| Laryngeal Neoplasms | 1 | 2022 | 42 | 0.190 |
Why?
| ROC Curve | 2 | 2014 | 236 | 0.190 |
Why?
| Family Therapy | 1 | 2001 | 11 | 0.190 |
Why?
| Plant Proteins | 1 | 2022 | 67 | 0.190 |
Why?
| Family Characteristics | 1 | 2001 | 50 | 0.190 |
Why?
| Korea | 3 | 2023 | 7 | 0.180 |
Why?
| Risk | 2 | 2019 | 315 | 0.180 |
Why?
| Child | 5 | 2014 | 6862 | 0.170 |
Why?
| Cardiac Surgical Procedures | 2 | 2013 | 303 | 0.170 |
Why?
| Survival Rate | 3 | 2020 | 906 | 0.170 |
Why?
| Depression | 1 | 2024 | 571 | 0.170 |
Why?
| Sleep Initiation and Maintenance Disorders | 1 | 2019 | 40 | 0.160 |
Why?
| Hyperglycemia | 1 | 2019 | 81 | 0.160 |
Why?
| Breakfast | 1 | 2019 | 15 | 0.160 |
Why?
| Anti-Mullerian Hormone | 1 | 2018 | 4 | 0.160 |
Why?
| Parkinson Disease | 1 | 2021 | 145 | 0.160 |
Why?
| Hydrogen-Ion Concentration | 1 | 2018 | 177 | 0.160 |
Why?
| Vegetables | 1 | 2018 | 63 | 0.150 |
Why?
| Epigenesis, Genetic | 1 | 2022 | 371 | 0.150 |
Why?
| Mouth | 1 | 2018 | 31 | 0.150 |
Why?
| Glycemic Index | 1 | 2018 | 3 | 0.150 |
Why?
| Carcinoma, Hepatocellular | 1 | 2020 | 196 | 0.150 |
Why?
| Dietary Fats | 1 | 2018 | 125 | 0.150 |
Why?
| Fruit | 1 | 2018 | 113 | 0.150 |
Why?
| Periodontal Index | 2 | 2016 | 9 | 0.150 |
Why?
| Diabetic Neuropathies | 1 | 2018 | 49 | 0.150 |
Why?
| South Carolina | 2 | 2014 | 23 | 0.150 |
Why?
| Hypercholesterolemia | 1 | 2017 | 36 | 0.150 |
Why?
| Cluster Analysis | 1 | 2018 | 233 | 0.150 |
Why?
| Waist-Hip Ratio | 1 | 2017 | 6 | 0.140 |
Why?
| Tonometry, Ocular | 1 | 2016 | 5 | 0.140 |
Why?
| Longitudinal Studies | 4 | 2024 | 700 | 0.140 |
Why?
| Brain Ischemia | 1 | 2018 | 157 | 0.140 |
Why?
| Liver Neoplasms | 1 | 2020 | 331 | 0.140 |
Why?
| Stomach Neoplasms | 1 | 2020 | 187 | 0.130 |
Why?
| Anthropometry | 1 | 2016 | 92 | 0.130 |
Why?
| C-Reactive Protein | 1 | 2016 | 143 | 0.130 |
Why?
| Alcohol Drinking | 2 | 2015 | 221 | 0.130 |
Why?
| Blepharoptosis | 1 | 2015 | 13 | 0.130 |
Why?
| Reference Values | 1 | 2015 | 309 | 0.120 |
Why?
| Texas | 1 | 2015 | 143 | 0.120 |
Why?
| Adrenergic Uptake Inhibitors | 1 | 2014 | 15 | 0.120 |
Why?
| Analysis of Variance | 2 | 2015 | 563 | 0.120 |
Why?
| Patient Compliance | 1 | 2016 | 230 | 0.120 |
Why?
| Conduct Disorder | 1 | 2014 | 9 | 0.120 |
Why?
| Age Distribution | 1 | 2015 | 169 | 0.120 |
Why?
| Myopia | 1 | 2014 | 8 | 0.120 |
Why?
| Food Supply | 1 | 2015 | 90 | 0.120 |
Why?
| Neoplasm Staging | 1 | 2017 | 749 | 0.110 |
Why?
| Social Class | 1 | 2015 | 96 | 0.110 |
Why?
| Toothbrushing | 1 | 2013 | 2 | 0.110 |
Why?
| Linear Models | 1 | 2015 | 279 | 0.110 |
Why?
| Metabolome | 1 | 2015 | 92 | 0.110 |
Why?
| Anxiety Disorders | 1 | 2014 | 125 | 0.110 |
Why?
| Health Status Indicators | 1 | 2014 | 83 | 0.110 |
Why?
| Exercise Test | 1 | 2014 | 129 | 0.110 |
Why?
| Asthma | 1 | 2017 | 282 | 0.110 |
Why?
| Pregnancy | 2 | 2022 | 2609 | 0.110 |
Why?
| Vitamin D Deficiency | 1 | 2014 | 44 | 0.110 |
Why?
| Metabolomics | 1 | 2015 | 133 | 0.110 |
Why?
| Vitamin D | 1 | 2014 | 88 | 0.110 |
Why?
| Smoking | 2 | 2015 | 506 | 0.110 |
Why?
| Organ Size | 1 | 2014 | 223 | 0.110 |
Why?
| Ibuprofen | 1 | 2013 | 20 | 0.110 |
Why?
| Sex Characteristics | 2 | 2015 | 192 | 0.110 |
Why?
| Anti-Arrhythmia Agents | 1 | 2013 | 81 | 0.110 |
Why?
| Tachycardia, Supraventricular | 1 | 2013 | 39 | 0.110 |
Why?
| Ductus Arteriosus, Patent | 1 | 2013 | 38 | 0.110 |
Why?
| Voluntary Health Agencies | 1 | 2012 | 4 | 0.110 |
Why?
| Heart Septal Defects, Atrial | 1 | 2013 | 43 | 0.110 |
Why?
| International Agencies | 1 | 2012 | 13 | 0.110 |
Why?
| Leukocyte Count | 1 | 2013 | 72 | 0.100 |
Why?
| Cardiovascular Agents | 1 | 2013 | 54 | 0.100 |
Why?
| Albuminuria | 1 | 2012 | 45 | 0.100 |
Why?
| Absorptiometry, Photon | 1 | 2013 | 155 | 0.100 |
Why?
| Central Nervous System Stimulants | 1 | 2014 | 205 | 0.100 |
Why?
| Awareness | 1 | 2012 | 28 | 0.100 |
Why?
| Catheter Ablation | 1 | 2013 | 122 | 0.100 |
Why?
| Guanosine | 1 | 2001 | 7 | 0.100 |
Why?
| Disease Management | 1 | 2013 | 175 | 0.100 |
Why?
| Sensitivity and Specificity | 1 | 2014 | 871 | 0.100 |
Why?
| Needs Assessment | 1 | 2012 | 133 | 0.090 |
Why?
| Software Design | 1 | 2001 | 13 | 0.090 |
Why?
| Severity of Illness Index | 3 | 2020 | 959 | 0.090 |
Why?
| Down-Regulation | 1 | 2012 | 342 | 0.090 |
Why?
| Medical Records Systems, Computerized | 1 | 2001 | 39 | 0.090 |
Why?
| Diet Surveys | 2 | 2022 | 32 | 0.090 |
Why?
| Puerto Rico | 2 | 2019 | 15 | 0.080 |
Why?
| Practice Guidelines as Topic | 1 | 2012 | 459 | 0.080 |
Why?
| Arkansas | 2 | 2025 | 1988 | 0.080 |
Why?
| Reproducibility of Results | 2 | 2023 | 1195 | 0.080 |
Why?
| Muscle, Skeletal | 1 | 2014 | 781 | 0.070 |
Why?
| Heart Defects, Congenital | 1 | 2013 | 590 | 0.070 |
Why?
| Primary Health Care | 1 | 2001 | 363 | 0.070 |
Why?
| Multivariate Analysis | 2 | 2020 | 581 | 0.070 |
Why?
| Life Style | 2 | 2022 | 140 | 0.070 |
Why?
| Chromium | 1 | 2025 | 7 | 0.060 |
Why?
| Poverty Areas | 1 | 2024 | 37 | 0.060 |
Why?
| Air Pollution | 1 | 2025 | 45 | 0.060 |
Why?
| Insurance, Health | 1 | 2024 | 131 | 0.050 |
Why?
| Insurance Coverage | 1 | 2024 | 110 | 0.050 |
Why?
| Predictive Value of Tests | 2 | 2017 | 921 | 0.050 |
Why?
| Poverty | 1 | 2024 | 206 | 0.050 |
Why?
| Diet, Vegetarian | 1 | 2022 | 6 | 0.050 |
Why?
| Zygoma | 1 | 2001 | 2 | 0.050 |
Why?
| Thinness | 1 | 2022 | 45 | 0.050 |
Why?
| Orbit | 1 | 2001 | 28 | 0.050 |
Why?
| Longevity | 1 | 2022 | 79 | 0.050 |
Why?
| Registries | 1 | 2024 | 527 | 0.050 |
Why?
| Life Change Events | 1 | 2001 | 36 | 0.050 |
Why?
| Professional-Family Relations | 1 | 2001 | 45 | 0.050 |
Why?
| Healthcare Disparities | 1 | 2024 | 279 | 0.050 |
Why?
| Chi-Square Distribution | 1 | 2001 | 280 | 0.050 |
Why?
| Geriatric Assessment | 1 | 2001 | 114 | 0.050 |
Why?
| Mortality | 1 | 2021 | 97 | 0.040 |
Why?
| Psychometrics | 1 | 2001 | 228 | 0.040 |
Why?
| Echocardiography | 2 | 2013 | 390 | 0.040 |
Why?
| Family | 1 | 2001 | 177 | 0.040 |
Why?
| Actinomyces | 1 | 2019 | 9 | 0.040 |
Why?
| Poultry | 1 | 2019 | 18 | 0.040 |
Why?
| Mental Health | 1 | 2001 | 223 | 0.040 |
Why?
| Veterinary Medicine | 1 | 1978 | 8 | 0.040 |
Why?
| Receptors, Progesterone | 1 | 2019 | 63 | 0.040 |
Why?
| Receptor, erbB-2 | 1 | 2019 | 74 | 0.040 |
Why?
| Animals | 4 | 2022 | 13141 | 0.040 |
Why?
| Reflex | 1 | 2018 | 31 | 0.040 |
Why?
| Computers | 1 | 1978 | 49 | 0.040 |
Why?
| Biometry | 1 | 2017 | 21 | 0.040 |
Why?
| Pharmaceutical Preparations | 1 | 1978 | 77 | 0.040 |
Why?
| DNA Methylation | 1 | 2022 | 546 | 0.040 |
Why?
| Dietary Carbohydrates | 1 | 2018 | 90 | 0.040 |
Why?
| Hemodynamics | 1 | 2018 | 264 | 0.030 |
Why?
| Survival Analysis | 1 | 2018 | 670 | 0.030 |
Why?
| Disease Progression | 1 | 2018 | 821 | 0.030 |
Why?
| Infant | 2 | 2013 | 3584 | 0.030 |
Why?
| Eating | 1 | 2015 | 158 | 0.030 |
Why?
| Refraction, Ocular | 1 | 2014 | 7 | 0.030 |
Why?
| Valsalva Maneuver | 1 | 2013 | 7 | 0.030 |
Why?
| Military Medicine | 1 | 1983 | 23 | 0.030 |
Why?
| Posture | 1 | 2013 | 60 | 0.030 |
Why?
| Brain | 1 | 2021 | 1311 | 0.030 |
Why?
| Regression Analysis | 1 | 2013 | 395 | 0.030 |
Why?
| Heart Rate | 1 | 2013 | 301 | 0.020 |
Why?
| Anti-Inflammatory Agents, Non-Steroidal | 1 | 2013 | 122 | 0.020 |
Why?
| Lipoproteins, HDL | 1 | 2011 | 18 | 0.020 |
Why?
| Mercaptoethanol | 1 | 2001 | 6 | 0.020 |
Why?
| Methanol | 1 | 2001 | 10 | 0.020 |
Why?
| Chromatography, Thin Layer | 1 | 2001 | 25 | 0.020 |
Why?
| Spectrophotometry, Ultraviolet | 1 | 2001 | 33 | 0.020 |
Why?
| Data Display | 1 | 2001 | 10 | 0.020 |
Why?
| Magnetic Resonance Spectroscopy | 1 | 2001 | 246 | 0.020 |
Why?
| Mass Spectrometry | 1 | 2001 | 285 | 0.020 |
Why?
| Diastole | 1 | 2010 | 71 | 0.020 |
Why?
| Systole | 1 | 2010 | 71 | 0.020 |
Why?
| Child, Preschool | 1 | 2013 | 3896 | 0.010 |
Why?
| Treatment Outcome | 1 | 2013 | 5203 | 0.010 |
Why?
| Occipital Bone | 1 | 2001 | 5 | 0.010 |
Why?
| Palate | 1 | 2001 | 13 | 0.010 |
Why?
| Cephalometry | 1 | 2001 | 19 | 0.010 |
Why?
| Skull Base | 1 | 2001 | 32 | 0.010 |
Why?
| Mandible | 1 | 2001 | 28 | 0.010 |
Why?
| Statistics as Topic | 1 | 2001 | 88 | 0.010 |
Why?
| Skull | 1 | 2001 | 77 | 0.010 |
Why?
| Dose-Response Relationship, Radiation | 1 | 2001 | 184 | 0.010 |
Why?
| Radiation Injuries, Experimental | 1 | 2001 | 82 | 0.010 |
Why?
| Random Allocation | 1 | 2001 | 288 | 0.010 |
Why?
| Rabbits | 1 | 2001 | 376 | 0.010 |
Why?
| Radiation Dosage | 1 | 2001 | 159 | 0.010 |
Why?
| Image Processing, Computer-Assisted | 1 | 2001 | 243 | 0.010 |
Why?
| Bone Density | 1 | 2001 | 386 | 0.010 |
Why?
| USSR | 1 | 1978 | 1 | 0.010 |
Why?
| Animal Diseases | 1 | 1978 | 4 | 0.010 |
Why?
| Germany, East | 1 | 1978 | 4 | 0.010 |
Why?
| Disease Models, Animal | 1 | 2001 | 1419 | 0.010 |
Why?
| Tomography, X-Ray Computed | 1 | 2001 | 1160 | 0.010 |
Why?
| History, Early Modern 1451-1600 | 1 | 1983 | 1 | 0.010 |
Why?
| History, Modern 1601- | 1 | 1983 | 2 | 0.010 |
Why?
| History, Medieval | 1 | 1983 | 6 | 0.010 |
Why?
| History, Ancient | 1 | 1983 | 10 | 0.010 |
Why?
| Netherlands | 1 | 1983 | 16 | 0.010 |
Why?
|
|
Park's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically based on a person's publications. Keywords from attributed publications are matched to keywords from the MeSH. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|